- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04903691
Changes in Fitness and Strength in Postoperative Cardiac Patients Undergoing Exercise Therapy: Biological and Functional Mechanisms of Recovery
June 7, 2023 updated by: Yale University
This study seeks to determine the biological, physiological and psychological effects of supervised exercise programs in patients surviving open heart surgery.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Patients who have survived open heart surgery and cleared for exercise by their clinical team will be approached to enter a 12-week exercise program.
Patient will consent to train with a personalized program either in strength, functional or aerobic exercise in a supervised setting for 3 sessions per week for a minimum of 12-week period.
The aim is to enroll males and females in this arm in 1:1 ratio if possible.
A separate cohort of patients entering cardiac rehabilitation (CR) will also be included for comparison.
The CR program includes three sessions per week for a maximum of 36 sessions.
The enrollment and retention rates in CR will be monitored.
In this study, five patients who have undergone cardiac surgery and chosen not to participate in organized exercise program will be included.
Participants cardiorespiratory fitness will be measured either using a questionnaire or in person.
Through each phase of the study, the change in fitness, strength, biomarkers, body composition, cognition and psychosocial recovery will be monitored.
All subjects will undergo detailed assessments in the research lab 2 weeks before and after finishing or exiting exercise program.
A short (3-month) and long term (12-month) outcomes including rates of survival, major adverse cardiac events, cognition and cardiac-related hospitalizations will be collected as well during the study.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06511
- Yale Church Street Research Unit (CSRU)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients at least 18 years of age or older who undergo open heart surgery and who intend to enroll in a cardiac rehabilitation program.
Exclusion Criteria:
- Patients may be excluded for inability to read or understand English
- suffering from a condition that precludes informed consent (for example, cardiogenic shock)
- hemodynamic instability
- ongoing trauma or substance overdoses
- known intellectual or developmental delay
- communication impairment
- active users of illicit substances
- active psychiatric illness
- inability to attend cardiac rehabilitation (homeless, in police custody, or living out of state)
- inability to exercise (lower limb amputation, bedridden, decompensated heart failure, ongoing cancer treatment)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise training
130 patients who underwent open heart surgery and are cleared for exercise.These will include patients who enter supervised cardiac rehabilitation as well as patients who enter a supervised exercise program focusing strength training, endurance of functional training.
|
Participants who enrolled in cardiac exercise program
|
|
No Intervention: Additional controls
5 patients who choose not to enter any organized exercise program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cardiorespiratory fitness
Time Frame: Baseline and 2 weeks after completing exercise program
|
Change in peak cardiorespiratory fitness as measured by metabolic equivalent (METS).
(Higher values indicate higher fitness)
|
Baseline and 2 weeks after completing exercise program
|
|
Change in strength
Time Frame: Baseline and 2 weeks after completing exercise program
|
Change in strength as measured by grip strength (Higher values indicate better strength).
|
Baseline and 2 weeks after completing exercise program
|
|
Change in functional fitness.
Time Frame: Baseline and 2 weeks after completing exercise program
|
Change in functional fitness as measured by the Short Physical Performance Battery (higher overall score or less time to completion indicates higher fitness)
|
Baseline and 2 weeks after completing exercise program
|
|
Change in cognition
Time Frame: Baseline and 2 weeks after completing exercise program
|
Measured by standardized tests of cognition such as Montreal Cognitive Assessment (MoCA) (Higher values indicate better cognition with scores less than 23-26 adjusting for education indicative of impaired cognition)
|
Baseline and 2 weeks after completing exercise program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Basmah Safdar, MD, Yale University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2021
Primary Completion (Actual)
September 30, 2021
Study Completion (Actual)
September 30, 2021
Study Registration Dates
First Submitted
May 21, 2021
First Submitted That Met QC Criteria
May 21, 2021
First Posted (Actual)
May 26, 2021
Study Record Updates
Last Update Posted (Actual)
June 9, 2023
Last Update Submitted That Met QC Criteria
June 7, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2000028739
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiorespiratory; Insufficiency, Due to A Procedure, Long-Term, Cardiac Surgery
-
University of LjubljanaRecruitingThe Focus is to Develop a Closed-loop Control System for Anaesthesia in Vitroretinal Surgery, Surgery Due to Expansive Processes in Head, and Long-term SedationSlovenia
-
Tel-Aviv Sourasky Medical CenterUnknownPatients Who Are in Need of Short or Long Term Rehabilitation Due to Neurological Event (Mainly Stroke) or Post Orthopedic SurgeryIsrael
-
Assiut UniversityNot yet recruitingHeart Diseases | Heart Valve Diseases | Acute Kidney Injury | Cardiopulmonary Arrest With Successful Resuscitation | Cardio-Renal Syndrome | Cardiac Disease | Coronary Artery Bypass Surgery | Cardiothoracic Surgery | Cardio-pulmonary Bypass | Cardiopulmonary Disease | Cardio Respiratory Arrest | Heart Shock | Acute...
-
RTI InternationalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationPrimary Hyperoxaluria Type 3 | Diabetes Mellitus | Hemophilia A | Hemophilia B | Hereditary Fructose Intolerance | Cystic Fibrosis | Factor VII Deficiency | Phenylketonurias | Sickle Cell Disease | Dravet Syndrome | Duchenne Muscular Dystrophy | Prader-Willi Syndrome | Fragile X Syndrome | Chronic Granulomatous Disease and other conditionsUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Moyamoya Disease | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar... and other conditionsUnited States, Australia
Clinical Trials on Cardiac Exercise Program
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Research Center in Physical...CompletedCoronary Artery DiseasePortugal
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiovascular Risk FactorBrazil
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
University of Castilla-La ManchaHospital Virgen de la LuzActive, not recruitingCardiovascular DiseasesSpain
-
Associacao de Investigacao de Cuidados de Suporte...Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.; University Institute...CompletedCardiovascular Diseases | Oncologic DisordersPortugal
-
Sheba Medical CenterThe Gertner InstituteUnknown
-
Yousra Hisham Abdel FattahDiaa Mohamed Mohasseb; Mahmoud Mohamed Hassanein; Gihan Younis El-tantawi; Aya...CompletedMyocardial Infarction | Diabetes Mellitus, Type 2 | Diabetic Peripheral Neuropathy
-
Fundación Pública Andaluza para la Investigación...UnknownHomebased Cardiac Rehabilitation Program After Ischemic Heart DiseaseSpain
-
Muhammed Onur HanedanCompletedCardiac Rehabilitation | Coronary Artery Bypass SurgeryTurkey
-
Chinese PLA General HospitalBeijing Normal UniversityUnknownCoronary Heart Disease | Chronic Coronary SyndromeChina